🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in India / NCT07030218
Active, not recruiting Observational

A Warning Red Flag Classification System to Predict Risk of Vasovagal Event During Office Hysteroscopy

NCT07030218 · tracked via the Priya Life Science India tracker
Sponsor
Tanvir Hospital
Phase
Observational
Started
2025-06-20
Last updated
2026-06-30

Condition(s) studied

Vasovagal Syncope (VVS)Presyncope

Investigational drug(s) / intervention(s)

Office hysteroscopy

Office hysteroscopy: In office hysteroscopy will utilize 1.9-2.9 mm hysteroscopes (primarily Bettocchi) by the technique of vaginoscopy, without anesthesia or up to level 3a analgesia, in accordance with International Consensus Statement for Recommended Terminology Describing Hysteroscopic Procedures. The choice of distension medium and hysteroscope is left to the operator's discretion. A nurse positioned at the head of the patient will record signs and symptoms of VVR/VVS.

Study summary

The goal of this pilot cross sectional study is to identify participants at risk of vasovagal reaction/syncope(VVR/VVS) during office hysteroscopy. A predictive red flag classification system is being studied to improve procedural safety during office hysteroscopy. Researchers will perform office hysteroscopy as per the standard protocol by vaginoscopic technique. A nurse positioned at the head side of the participant will record signs and symptoms of VVR/VVS. The participant will be asked of the severity of the pain experienced during office hysteroscopy in relation to their menstrual cycle. The procedure will be discontinued at any point the participant wishes to stop.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * Women ≥18 years * Prior gynecological care * Informed consent provided Exclusion Criteria: * Inability to consent * Psychiatric disorders or anxiolytic use * Use of dilators or anesthesia above level 3a * Family history of VVS

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tanvir Hospital Hyderabad Telangana
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07030218 on ClinicalTrials.gov ↗ ← All trials in India